Prescription drug claim denials by U.S. insurers rose 25% from 2016-2023, according to a new analysis of more than 4B medical ...

Long-term oil demand growth and Schlumberger's AI-driven digital initiatives provide powerful tailwinds for sustained ...

Arq recognized that the PAC market is maturing, and it is investing in adding GAC capacity. Read why ARQ stock is not ...

LTPZ suffered a steep price decline since 2021, but I expect a recovery as inflation concerns persist and demand for TIPS ...

TXO Partners offers a 16.3% yield backed by low-decline assets, insider confidence, and growth via acquisition. Read why TXO ...

Holdings has accelerated revenue growth and expanded gross margins. Read what supports a compelling long-term investment ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

Stay ahead on Wall Street's key earnings and economic updates! Insights on Tesla, Alphabet, Federal Reserve policies, and ...

Tesla has room to increase its market share, but margin expansion faces execution risk. Click here to read why I rate TSLA ...

The US dollar rose against the G10 currencies and most emerging market currencies last week. The dollar dropped precipitously ...

JMBS offers high-yield agency MBS exposure with lower volatility than junk bonds and upside from falling rates. Learn why ...

First Financial Bankshares shows strong growth and profitability, but high valuation and deposit risks temper enthusiasm.